Magnesium in PDB 6uk1: Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
Enzymatic activity of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
All present enzymatic activity of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr):
5.6.1.6;
Protein crystallography data
The structure of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr), PDB code: 6uk1
was solved by
C.Wang,
S.M.Vorobiev,
R.M.Vernon,
N.Khazanov,
H.Senderowitz,
J.D.Forman-Kay,
J.F.Hunt,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
64.41 /
2.69
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
95.063,
60.132,
105.160,
90.00,
99.57,
90.00
|
R / Rfree (%)
|
27.3 /
30.4
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
(pdb code 6uk1). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 4 binding sites of Magnesium where determined in the
Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr), PDB code: 6uk1:
Jump to Magnesium binding site number:
1;
2;
3;
4;
Magnesium binding site 1 out
of 4 in 6uk1
Go back to
Magnesium Binding Sites List in 6uk1
Magnesium binding site 1 out
of 4 in the Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1502
b:20.9
occ:1.00
|
O1G
|
A:ATP1501
|
2.0
|
19.8
|
1.0
|
O
|
A:HOH1601
|
2.1
|
22.3
|
1.0
|
O
|
D:HOH1612
|
2.1
|
22.3
|
1.0
|
O
|
A:HOH1605
|
2.1
|
19.4
|
1.0
|
OG
|
A:SER1251
|
2.1
|
22.2
|
1.0
|
O1B
|
A:ATP1501
|
2.4
|
17.0
|
1.0
|
O3G
|
D:ATP1501
|
2.8
|
43.6
|
1.0
|
CB
|
A:SER1251
|
3.2
|
15.6
|
1.0
|
PG
|
A:ATP1501
|
3.3
|
28.1
|
1.0
|
PB
|
A:ATP1501
|
3.7
|
25.3
|
1.0
|
O3G
|
A:ATP1501
|
3.7
|
34.8
|
1.0
|
O3B
|
A:ATP1501
|
3.9
|
32.4
|
1.0
|
O2A
|
A:ATP1501
|
4.0
|
25.0
|
1.0
|
PG
|
D:ATP1501
|
4.1
|
32.6
|
1.0
|
OE1
|
A:GLU1371
|
4.2
|
28.7
|
1.0
|
OD2
|
A:ASP1370
|
4.2
|
35.2
|
1.0
|
O1G
|
D:ATP1501
|
4.2
|
38.4
|
1.0
|
CA
|
A:SER1251
|
4.4
|
19.5
|
1.0
|
N
|
A:SER1251
|
4.4
|
15.6
|
1.0
|
OD1
|
A:ASP1370
|
4.4
|
29.4
|
1.0
|
O2G
|
A:ATP1501
|
4.5
|
43.8
|
1.0
|
O2B
|
A:ATP1501
|
4.6
|
5.0
|
1.0
|
O2G
|
D:ATP1501
|
4.7
|
15.7
|
1.0
|
CG
|
A:ASP1370
|
4.7
|
25.2
|
1.0
|
O3A
|
A:ATP1501
|
4.7
|
20.4
|
1.0
|
PA
|
A:ATP1501
|
4.8
|
33.0
|
1.0
|
O
|
A:HOH1610
|
4.8
|
20.1
|
1.0
|
O1A
|
A:ATP1501
|
4.9
|
41.2
|
1.0
|
OG1
|
D:THR1246
|
5.0
|
39.5
|
1.0
|
|
Magnesium binding site 2 out
of 4 in 6uk1
Go back to
Magnesium Binding Sites List in 6uk1
Magnesium binding site 2 out
of 4 in the Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg1502
b:69.7
occ:1.00
|
O
|
B:HOH1601
|
2.1
|
48.7
|
1.0
|
OG
|
B:SER1251
|
2.1
|
79.0
|
1.0
|
O
|
C:HOH1605
|
2.1
|
38.8
|
1.0
|
OD1
|
B:ASP1370
|
2.2
|
82.3
|
1.0
|
OE2
|
B:GLU1371
|
2.3
|
74.5
|
1.0
|
OD2
|
B:ASP1370
|
2.3
|
72.5
|
1.0
|
CG
|
B:ASP1370
|
2.6
|
69.2
|
1.0
|
O1G
|
B:ATP1501
|
2.8
|
49.9
|
1.0
|
O1B
|
B:ATP1501
|
2.9
|
37.3
|
1.0
|
CB
|
B:SER1251
|
3.5
|
48.9
|
1.0
|
CD
|
B:GLU1371
|
3.5
|
62.0
|
1.0
|
N
|
B:SER1251
|
4.0
|
49.0
|
1.0
|
O
|
B:HOH1603
|
4.0
|
37.4
|
1.0
|
CB
|
B:ASP1370
|
4.1
|
59.4
|
1.0
|
CA
|
B:SER1251
|
4.1
|
49.0
|
1.0
|
CG
|
B:GLU1371
|
4.2
|
58.2
|
1.0
|
O1G
|
C:ATP1501
|
4.2
|
61.0
|
1.0
|
PG
|
B:ATP1501
|
4.2
|
30.3
|
1.0
|
PB
|
B:ATP1501
|
4.3
|
33.8
|
1.0
|
O
|
C:HOH1609
|
4.4
|
25.6
|
1.0
|
OE1
|
B:GLU1371
|
4.4
|
57.8
|
1.0
|
CE1
|
B:HIS1375
|
4.5
|
57.8
|
1.0
|
O
|
B:HOH1608
|
4.7
|
26.5
|
1.0
|
ND1
|
B:HIS1375
|
4.8
|
58.0
|
1.0
|
CB
|
B:LYS1250
|
4.8
|
48.8
|
1.0
|
O3B
|
B:ATP1501
|
4.8
|
33.6
|
1.0
|
O2G
|
B:ATP1501
|
4.9
|
44.1
|
1.0
|
CE
|
B:LYS1250
|
4.9
|
48.3
|
1.0
|
O2B
|
B:ATP1501
|
4.9
|
31.8
|
1.0
|
CA
|
B:ASP1370
|
4.9
|
59.3
|
1.0
|
C
|
B:LYS1250
|
4.9
|
49.1
|
1.0
|
C
|
B:ASP1370
|
5.0
|
58.9
|
1.0
|
CB
|
B:GLU1371
|
5.0
|
58.1
|
1.0
|
|
Magnesium binding site 3 out
of 4 in 6uk1
Go back to
Magnesium Binding Sites List in 6uk1
Magnesium binding site 3 out
of 4 in the Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg1502
b:42.2
occ:1.00
|
O
|
C:HOH1608
|
2.1
|
30.6
|
1.0
|
O
|
C:HOH1601
|
2.1
|
25.4
|
1.0
|
OG
|
C:SER1251
|
2.2
|
63.1
|
1.0
|
O2G
|
C:ATP1501
|
2.2
|
77.7
|
1.0
|
O1B
|
C:ATP1501
|
2.4
|
30.3
|
1.0
|
O3B
|
C:ATP1501
|
2.5
|
63.8
|
1.0
|
PG
|
C:ATP1501
|
2.9
|
54.5
|
1.0
|
O1A
|
C:ATP1501
|
2.9
|
12.8
|
1.0
|
PB
|
C:ATP1501
|
3.0
|
41.0
|
1.0
|
O3G
|
B:ATP1501
|
3.0
|
24.6
|
1.0
|
CB
|
C:SER1251
|
3.1
|
63.3
|
1.0
|
O1G
|
C:ATP1501
|
3.8
|
61.0
|
1.0
|
O3A
|
C:ATP1501
|
3.9
|
50.3
|
1.0
|
PA
|
C:ATP1501
|
3.9
|
43.0
|
1.0
|
O3G
|
C:ATP1501
|
4.1
|
47.2
|
1.0
|
O2B
|
C:ATP1501
|
4.2
|
27.8
|
1.0
|
N
|
C:SER1251
|
4.3
|
63.3
|
1.0
|
CA
|
C:SER1251
|
4.3
|
63.4
|
1.0
|
PG
|
B:ATP1501
|
4.4
|
30.3
|
1.0
|
O2A
|
C:ATP1501
|
4.5
|
32.1
|
1.0
|
OD2
|
C:ASP1370
|
4.7
|
48.1
|
1.0
|
O
|
C:HOH1609
|
4.7
|
25.6
|
1.0
|
O2G
|
B:ATP1501
|
4.7
|
44.1
|
1.0
|
O
|
B:HOH1603
|
4.8
|
37.4
|
1.0
|
OE1
|
C:GLU1371
|
4.9
|
47.1
|
1.0
|
|
Magnesium binding site 4 out
of 4 in 6uk1
Go back to
Magnesium Binding Sites List in 6uk1
Magnesium binding site 4 out
of 4 in the Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Crystal Structure of Nucleotide-Binding Domain 2 (NBD2) of the Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg1502
b:13.3
occ:1.00
|
O1B
|
D:ATP1501
|
2.1
|
17.3
|
1.0
|
O2G
|
D:ATP1501
|
2.1
|
15.7
|
1.0
|
O
|
D:HOH1602
|
2.1
|
9.9
|
1.0
|
O
|
D:HOH1610
|
2.1
|
15.1
|
1.0
|
OG
|
D:SER1251
|
2.2
|
17.8
|
1.0
|
O1A
|
D:ATP1501
|
3.0
|
22.7
|
1.0
|
O3G
|
A:ATP1501
|
3.0
|
34.8
|
1.0
|
CB
|
D:SER1251
|
3.1
|
17.6
|
1.0
|
PG
|
D:ATP1501
|
3.2
|
32.6
|
1.0
|
PB
|
D:ATP1501
|
3.3
|
29.6
|
1.0
|
O3B
|
D:ATP1501
|
3.5
|
26.6
|
1.0
|
O3G
|
D:ATP1501
|
3.8
|
43.6
|
1.0
|
PA
|
D:ATP1501
|
4.0
|
30.3
|
1.0
|
O3A
|
D:ATP1501
|
4.2
|
16.5
|
1.0
|
N
|
D:SER1251
|
4.2
|
25.1
|
1.0
|
CA
|
D:SER1251
|
4.3
|
27.8
|
1.0
|
PG
|
A:ATP1501
|
4.3
|
28.1
|
1.0
|
O2B
|
D:ATP1501
|
4.4
|
8.3
|
1.0
|
O2G
|
A:ATP1501
|
4.4
|
43.8
|
1.0
|
O2A
|
D:ATP1501
|
4.5
|
54.4
|
1.0
|
O1G
|
D:ATP1501
|
4.5
|
38.4
|
1.0
|
OD2
|
D:ASP1370
|
4.6
|
34.9
|
1.0
|
OE1
|
D:GLU1371
|
4.7
|
35.4
|
1.0
|
OD1
|
D:ASP1370
|
4.9
|
30.0
|
1.0
|
|
Reference:
C.Wang,
S.Vorobiev,
R.M.Vernon,
N.Khazanov,
H.Senderowitz,
J.D.Forman-Kay,
J.F.Hunt.
A Thermodynamically Stabilized Form of the Second Nucleotide Binding Domain From Human Cftr Shows A Catalytically Inactive Conformation To Be Published.
Page generated: Tue Oct 1 21:06:19 2024
|